In a continued mission to reduce the global burden of noncommunicable diseases (NCDs) such as cardiovascular disease and diabetes Medtronic, Inc. and the Medtronic Foundation announced a new commitment designed to improve healthcare systems and increase access to life saving therapies in lower and middle income countries.
In addition to the company’s focus on improving access to critical medical technologies in lower and middle income countries, the commitment includes an additional $3.4 million in Medtronic Foundation grants to support international health programs specifically designed to address prevention, treatment and control of NCDs.
Medtronic is focusing activities in three primary areas: global policy and advocacy, strengthening health systems and developing innovative therapies, and healthcare delivery models in countries around the world.
Since September 2010, the Medtronic Foundation has committed $3.8 million in grants to support international programs related to Medtronic’s overall strategic effort, including a $1 million founding grant to the NCD Alliance, a coalition of nonprofit organizations charged with preparing data driven plans and recommendations for the United Nations High Level Meeting on the prevention and control of noncommunicable diseases, being held September 19-20 in New York City.
